🇺🇸 FDA
Pipeline program

ELX-02

EL-008

Phase 1 small_molecule completed

Quick answer

ELX-02 for Impaired Renal Function is a Phase 1 program (small_molecule) at Eloxx Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Eloxx Pharmaceuticals
Indication
Impaired Renal Function
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials